<!doctype html>
<html>
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width">
<title></title>
<link rel="stylesheet" href="css/style.css">
</head>

<body>

<header>
  <div class="l"><a href="javascript:history.back();"><span>left</span></a></div>
  <p class="title"><a href="index.html">社外秘 研修資料</a></p>
  <div class="r"><a href="250.html"><span>right</span></a></div>
</header>

<div class="wrap">

  <section>
    <h1 class="tit">TNF阻害薬効果不十分症例にはNon-TNF製剤が良い</h1>
  </section>
  <section>
    <p class="txt big"><strong><u>ROC study　"<font color="#00B050">R</font>otation of anti-TNF <font color="#00B050">O</font>r <font color="#00B050">C</font>hange of class of biologic“</u></strong></p>
    <p class="txt sml"><strong>Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat RA in Patients with Insufficient Response to a First Anti-TNF Drug</strong></p>
    <ul class="circle">
    	<li><span>●</span>オープンラベル　多施設無作為化臨床試験</li>
    	<li><span>●</span>TNF阻害薬を使用しても、DAS28≧3.2のRA患者300名をTNF阻害薬もしくはNon-TNF阻害薬に1:1に無作為割付し52週間観察した</li>
    </ul>
    <div class="img"><img src="img/200-1.png" alt=""></div>
    <div class="bluebox"><p>２nd-BIOとして、TNF製剤とNon-TNF製剤を無作為に割り付けし、52週後のDAS28を比較した結果、Non-TNF製剤で有意に疾患活動性が低かった</p></div>
    <div class="img"><img src="img/200-2.png" alt=""></div>
    <div class="img"><img src="img/200-3.png" alt=""></div>
    <p class="txt sml right"><a href="http://maps.ty.chugai-pharm.co.jp/Search/Detail.aspx?id=E56381&skey=91d5e667-4a59-492f-8599-e0767c130b7c">Gottenberg,J.E.et al;JAMA. 2016;316(11):1172-1180.</a></p>
  </section>
</div>

<footer>
  <div class="l"><a href="javascript:history.back();"><span>left</span></a></div>
  <div class="home"><a href="index.html"><span>HOME</span></a></div>
  <div class="r"><a href="250.html"><span>right</span></a></div>
  <div class="pagetop"><a href="javascript:scroll(0,0);">pagetop</a></div>
</footer>

<script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.2/jquery.min.js"></script>
<script src="js/common.js"></script>
</body>
</html>
